CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Logo

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

A contract research organization supporting drug discovery and development.

CRL | US

Overview

Corporate Details

ISIN(s):
US1598641074
LEI:
Country:
United States of America
Address:
251 BALLARDVALE ST, 1887 WILMINGTON

Description

Charles River Laboratories International, Inc. is a contract research organization (CRO) that provides products and services to support the drug discovery and development process. The company partners with pharmaceutical, biotechnology, and other organizations to accelerate the development and safe manufacture of new therapeutics. Its portfolio spans the early-stage research and development continuum, offering solutions in non-clinical safety assessment, research models, toxicology, and microbial testing. Charles River provides laboratory services compliant with Good Laboratory Practice (GLP) and Good Clinical Practice (GCP) standards, supporting clients from initial discovery through to the clinic and manufacturing.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2018-02-13 17:13
10-K
English 3.5 MB
2018-02-13 13:59
LIVE FILING
English 72.7 KB
2018-02-13 10:35 English 10.1 KB
2018-02-13 09:52
FORM 8-K
English 313.1 KB
2018-02-13 08:15
CHARLES RIVER LABORATORIES 8-K
English 52.9 KB
2018-02-08 18:58 English 12.0 KB
2018-02-07 09:15
PRIMARY DOCUMENT
English 6.3 KB
2018-02-06 19:46
PRIMARY DOCUMENT
English 6.4 KB
2018-01-29 17:37 English 13.6 KB
2018-01-26 15:11
PRIMARY DOCUMENT
English 6.7 KB
2018-01-26 15:08
PRIMARY DOCUMENT
English 6.8 KB
2018-01-26 13:38
PRIMARY DOCUMENT
English 6.6 KB
2018-01-26 13:20
PRIMARY DOCUMENT
English 6.6 KB
2018-01-26 13:13
PRIMARY DOCUMENT
English 6.6 KB
2018-01-23 19:38
PRIMARY DOCUMENT
English 6.0 KB

Automate Your Workflow. Get a real-time feed of all CHARLES RIVER LABORATORIES INTERNATIONAL, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Genprex, Inc. Logo
Clinical-stage gene therapy company developing therapies for cancer and diabetes.
United States of America
GNPX
Genxone Spolka Akcyjna Logo
A biotechnology company specializing in Next Generation Sequencing and medical diagnostics.
Poland
GX1
GeoVax Labs, Inc. Logo
Clinical-stage biotech developing vaccines and therapies for infectious diseases and cancer.
United States of America
GOVX
GH Research PLC Logo
Develops mebufotenin-based therapies for psychiatric and neurological disorders.
United States of America
GHRS
GI Innovation Inc. Logo
Researches and develops protein-based drugs for immuno-oncology and immunology.
South Korea
358570
Ginkgo Bioworks Holdings, Inc. Logo
Operates a horizontal platform for cell programming and synthetic biology.
United States of America
DNA
GRAIL, Inc. Logo
A healthcare company developing blood tests for multi-cancer early detection.
United States of America
GRAL
GT Biopharma, Inc. Logo
Clinical-stage immuno-oncology company developing therapies with its NK cell engager tech.
United States of America
GTBP
Guard Therapeutics International AB Logo
Clinical-stage biotech developing therapies to prevent acute kidney injury.
Sweden
GUARD
Gubra A/S Logo
Biotech and CRO focused on peptide drugs for metabolic and fibrotic diseases.
Denmark
GUBRA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.